Loss of ALPK3 has been associated with contractile dysfunction and dilated cardiomyopathy in both murine and human models [44], whereas truncating variants are linked to hypertrophic cardiomyopathy [43]. Here, ALPK3 is linked to dilated cardiomyopathy.